Table 1. Patient Demographics and Outcomes.
| Cannabis-induced Anxiety (N=196) | Other forms of Cannabis Toxicity (N=939) | P-value | |
| Age (years), Mean (SD) | 25.2 ± 9.6 | 28.5 ± 8.5 | < 0.001 |
| Gender (% female) | 115 (58.7%) | 461 (49.1%) | 0.015 |
| Race (% white) | 124 (63.2%) | 545 (58.0%) | 0.179 |
| Duration of symptoms (hours), median (IQR) | 6.1 (2.3 to 12.5) | 15.2 (3.6 to 16.9) | < 0.001 |
| Edible cannabis | 51 (26.0%) | 106 (11.2%) | < 0.001 |
| Medical comorbidities | 34 (17.3%) | 115 (12.2%) | 0.054 |
| Psych comorbidities | 37 (18.9%) | 96 (10.2%) | < 0.001 |
| Polysubstance abuse | 40 (20.4%) | 123 (13.1%) | 0.008 |
| Physical restraints | 12 (6.1%) | 33 (3.5%) | 0.089 |
| Length of stay (hours), median (IQR) | 2.3 (1.1 to 3.0) | 3.0 (1.2 to 4.5) | 0.063 |
| Outcomes: | |||
| Admitted | 15 (7.7%) | 76 (8.1%) | 0.851 |
| Psychiatric transfer | 24 (12.2%) | 34 (3.6%) | < 0.001 |
| Jail | 5 (2.6%) | 9 (1.0%) | 0.070 |